FLNC: Analyst Cuts Deepen as Bears Hold Ground

Fluence Energy heads into its November earnings with a battered stock, a relentless wave of analyst target cuts, and short sellers who have now held a 26% position for two consecutive weeks without any sign of retreat.

The analyst action this week is the sharpest development. Citigroup cut its price target from $20 to $11 on Tuesday, maintaining a Buy rating that now implies nearly double the current price of $5.93. That gap deserves a caveat: a $11 target on a $5.93 stock, from a firm still holding a positive rating, reflects just how dislocated sentiment has become rather than a credible near-term call. Truist followed a day earlier, trimming from $10 to $8 while staying at Hold. The wave did not start this week. Morgan Stanley cut from $15 to $9 on October 14, Susquehanna from $23 to $13 the same day, and Goldman Sachs downgraded outright in September, moving from Buy to Neutral and halving its target to $9. The consensus mean now sits at $8.35, nearly 41% above the current price, but the direction of that mean has been relentlessly downward for six weeks. The bear case is well-documented: automated welding at the Houston facility is still not operational, manual labour has replaced it at higher cost, and the company has absorbed roughly $65 million in late-delivery penalties and $85 million of logistics disruption. FY2026 revenue guidance was cut by $600 million to $2.4 billion, with adjusted EBITDA now guided to a $200 million loss. The bull case rests entirely on FY2027 recovery, with management targeting neutral to positive operating cash flow without external capital and approximately $350 million of cash exiting the year.

Short positioning has grown modestly but steadily since the previous note published on October 14. Short interest edged to 26.1% of the free float, up from 25.8% a week ago, continuing a build that has now added roughly 32% to the short position over the past month. The ORTEX short score has climbed to 71.8, the highest in the tracked window, and factor scores put the short score rank in the 4th percentile of the universe, meaning very few stocks score more bearishly. Yet the borrow market continues to offer no friction to this trade. Availability is running at 75%, meaning there is ample supply for new shorts to establish positions. Cost to borrow is near 0.72%, barely changed on the week and far below any level that would pressure the short trade. Options traders have moved further from a bearish posture: the put/call ratio dropped to 0.24, its lowest reading of the past 52 weeks and well below the 20-day average of 0.26. That divergence between heavy short interest and call-tilted options activity is worth watching. It could reflect covered calls being written against long positions, or genuine call-buying on a recovery thesis, but it is not consistent with a market that is adding defensive hedges.

The ownership structure adds a layer of complexity to the short thesis. Siemens holds 29% of shares outstanding, filed as a 13G passive holder, and AES holds a further 22%. Together they account for over half the stock. Qatar Investment Authority, whose stake is flagged as a 13D activist holder in ORTEX's EDGAR data, holds 8.3%, down from 8.9% at its prior filing, though as per the disclosure these stakes are event-driven around the 5% threshold and positions can shift without a further filing. The two board-level directors who bought shares in open-market purchases on September 21 at $7.36 each, a combined 17,000 shares worth roughly $125,000, represent the only insider buying signal in the recent window. It is modest in size and occurred more than a month ago, but it was discretionary and not under a 10b5-1 plan, which gives it more weight than a scheduled transaction would carry.

The earnings history offers little comfort for longs. The three most recent results have produced one-day drops of 17.6%, 7.3%, and 15.7% respectively. The next print is scheduled for November 25, giving the stock 35 days to find a floor. With EPS momentum scores at the bottom of the universe (1st percentile on both 30-day and 90-day measures) and the EV/EBITDA multiple rising sharply as EBITDA worsens, the valuation framework is almost entirely forward-looking on a FY2027 recovery that has not yet begun.

The key question heading into November 25 is whether management can demonstrate any operational progress at Houston: not a target date for welding automation, but actual cost and penalty data showing the bleed is narrowing.